Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

T-cell responses against 4-tert-butylphenol-exposed pigmented cells in a patient with occupational vitiligo.

Vrijman C, Willemsen KJ, Tjin EPM, Kammeyer A, van den Boorn JG, van der Veen JPW, Jungbauer FHW, Kardaun SH, Luiten RM.

Br J Dermatol. 2019 Feb 5. doi: 10.1111/bjd.17713. [Epub ahead of print] No abstract available.

PMID:
30719700
2.

Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.

Teulings HE, Tjin EPM, Willemsen KJ, van der Kleij S, Ter Meulen S, Kemp EH, Krebbers G, van Noesel CJM, Franken CLMC, Drijfhout JW, Melief CJM, Nieuweboer-Krobotova L, Nieweg OE, van der Hage JA, van der Veen JPW, Relyveld GN, Luiten RM.

Oncoimmunology. 2018 Jan 15;7(4):e1419113. doi: 10.1080/2162402X.2017.1419113. eCollection 2018.

3.

Optimising size and depth of punch grafts in autologous transplantation of vitiligo and piebaldism: a randomised controlled trial.

Komen L, Vrijman C, Prinsen CA, van der Veen JP, Luiten RM, Wolkerstorfer A.

J Dermatolog Treat. 2017 Feb;28(1):86-91. doi: 10.1080/09546634.2016.1179251. Epub 2016 Jun 16.

PMID:
27309418
4.

Vitiligo-like depigmentations as the first sign of melanoma: a retrospective case series from a tertiary vitiligo centre.

Teulings HE, Lommerts JE, Wolkerstorfer A, Nieuweboer-Krobotova L, Luiten RM, Bekkenk MW, van der Veen JP.

Br J Dermatol. 2017 Feb;176(2):503-506. doi: 10.1111/bjd.14790. Epub 2016 Nov 11. No abstract available.

PMID:
27273338
5.

Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years.

Teulings HE, Ceylan E, Overkamp M, Vrijman C, Bos JD, Nijsten TE, Wolkerstorfer A, Luiten RM, van der Veen JP.

Br J Dermatol. 2016 Oct;175(4):821-4. doi: 10.1111/bjd.14640. Epub 2016 Aug 3. No abstract available.

PMID:
27042816
6.

Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study.

Komen L, Vrijman C, Tjin EP, Krebbers G, de Rie MA, Luiten RM, van der Veen JP, Wolkerstorfer A.

J Am Acad Dermatol. 2015 Jul;73(1):170-2. doi: 10.1016/j.jaad.2015.03.036. No abstract available.

PMID:
26089056
7.

The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.

Komen L, van der Kraaij GE, van der Veen JP, de Rie MA, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2145-51. doi: 10.1111/jdv.13161. Epub 2015 Apr 13.

PMID:
25868111
8.

Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.

Komen L, da Graça V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JP.

Br J Dermatol. 2015 Feb;172(2):437-43. doi: 10.1111/bjd.13432. Epub 2015 Jan 8.

PMID:
25278165
9.

The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.

Teulings HE, Willemsen KJ, Glykofridis I, Krebbers G, Komen L, Kroon MW, Kemp EH, Wolkerstorfer A, van der Veen JP, Luiten RM, Tjin EP.

Pigment Cell Melanoma Res. 2014 Nov;27(6):1086-96. doi: 10.1111/pcmr.12294. Epub 2014 Aug 4.

PMID:
25043574
10.

Q-switched laser depigmentation in vitiligo, most effective in active disease.

Komen L, Zwertbroek L, Burger SJ, van der Veen JP, de Rie MA, Wolkerstorfer A.

Br J Dermatol. 2013 Dec;169(6):1246-51. doi: 10.1111/bjd.12571.

PMID:
23909405
11.

Long-term remission of folliculitis decalvans after treatment with the long-pulsed Nd:YAG laser.

Meesters AA, Van der Veen JP, Wolkerstorfer A.

J Dermatolog Treat. 2014 Apr;25(2):167-8. doi: 10.3109/09546634.2013.826340. Epub 2013 Aug 27.

PMID:
23875611
12.

High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo.

Kroon MW, Vrijman C, Chandeck C, Wind BS, Wolkerstorfer A, Luiten RM, Bos JD, Geskus RB, van Trotsenburg P, van der Veen JP.

Horm Res Paediatr. 2013;79:137-44. doi: 10.1159/000348388. Epub 2013 Mar 19.

PMID:
23548513
13.

Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis.

Teulings HE, Tjin EP, Willemsen KJ, Krebbers G, van Noesel CJ, Kemp EH, Nieuweboer-Krobotova L, van der Veen JP, Luiten RM.

Br J Dermatol. 2013 Apr;168(4):733-8. doi: 10.1111/bjd.12136. Epub 2013 Feb 27.

PMID:
23421690
14.

Provoking factors, including chemicals, in Dutch patients with vitiligo.

Vrijman C, Hosseinpour D, Bakker JG, Wolkerstorfer A, Bos JD, van der Veen JP, Luiten RM.

Br J Dermatol. 2013 May;168(5):1003-11. doi: 10.1111/bjd.12162.

PMID:
23252956
15.

Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.

Teulings HE, Overkamp M, Ceylan E, Nieuweboer-Krobotova L, Bos JD, Nijsten T, Wolkerstorfer AW, Luiten RM, van der Veen JP.

Br J Dermatol. 2013 Jan;168(1):162-71. doi: 10.1111/bjd.12111.

PMID:
23136900
16.

Long-pulsed 1064 nm Nd:YAG laser improves hypertrophic port-wine stains.

van Drooge AM, Bosveld B, van der Veen JP, de Rie MA, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1381-6. doi: 10.1111/jdv.12021. Epub 2012 Oct 24.

PMID:
23094931
17.

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, Wolkerstorfer A, Spuls PI.

Br J Dermatol. 2012 Dec;167(6):1224-35. doi: 10.1111/j.1365-2133.2012.11198.x. Epub 2012 Oct 5. Review.

PMID:
22860695
18.

Hypertrophy in port-wine stains: prevalence and patient characteristics in a large patient cohort.

van Drooge AM, Beek JF, van der Veen JP, van der Horst CM, Wolkerstorfer A.

J Am Acad Dermatol. 2012 Dec;67(6):1214-9. doi: 10.1016/j.jaad.2012.05.027. Epub 2012 Jun 28.

PMID:
22749320
19.

Digital image analysis vs. clinical assessment to evaluate repigmentation after punch grafting in vitiligo.

Linthorst Homan MW, Wolkerstorfer A, Sprangers MA, van der Veen JP.

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e235-8. doi: 10.1111/j.1468-3083.2012.04568.x. Epub 2012 May 23.

PMID:
22621363
20.

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JP, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A, Silverberg NB, Spritz RA.

Nat Genet. 2012 May 6;44(6):676-80. doi: 10.1038/ng.2272.

Supplemental Content

Loading ...
Support Center